A case of a 58 year-old woman with known hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract obstruction (LVOTO) (40 mmHg peak gradient) with mild symptoms (NYHA functional class II/IV) with beta blockers and disopyramide.
ALPK3 and hypertrophic cardiomyopathy: a new step forward to close the inheritability gap.
64 years-old Caucasian lady, with positive family history for sudden death (grandfather, 49 y/o).
She had been diagnosed with hypertrophic cardiomyopathy aged 50 after she was found with inverted T waves on routine ECG.
Take the Quiz
HOW-TO…Measure Intraventricular Obstruction in Hypertrophic Cardiomyopathy
- Hypertrophic cardiomyopathy – from the gene to the heart and from the patient to their family
- Hypertrophic cardiomyopathy - disease course and therapeutic strategies for patients
Congress Resources on Hypertrophic Cardiomyopathy
ESC Congress 2021
- Meet the Experts: cardiomyopathies and sudden cardiac death
- Meet the Experts: risk calculators to predict sudden cardiac death in cardiomyopathies. A blessing in disguise?
Like what you have read?
Find out more about the Council on Cardiovascular Genomics.